387 related articles for article (PubMed ID: 26908792)
1. Determinants of a Low CD4/CD8 Ratio in HIV-1-Infected Individuals Despite Long-term Viral Suppression.
Caby F; Guihot A; Lambert-Niclot S; Guiguet M; Boutolleau D; Agher R; Valantin MA; Tubiana R; Calvez V; Marcelin AG; Carcelain G; Autran B; Costagliola D; Katlama C
Clin Infect Dis; 2016 May; 62(10):1297-1303. PubMed ID: 26908792
[TBL] [Abstract][Full Text] [Related]
2. Asymptomatic CMV Replication During Early Human Immunodeficiency Virus (HIV) Infection Is Associated With Lower CD4/CD8 Ratio During HIV Treatment.
Smith DM; Nakazawa M; Freeman ML; Anderson CM; Oliveira MF; Little SJ; Gianella S
Clin Infect Dis; 2016 Dec; 63(11):1517-1524. PubMed ID: 27601222
[TBL] [Abstract][Full Text] [Related]
3. CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study.
Mussini C; Lorenzini P; Cozzi-Lepri A; Lapadula G; Marchetti G; Nicastri E; Cingolani A; Lichtner M; Antinori A; Gori A; d'Arminio Monforte A;
Lancet HIV; 2015 Mar; 2(3):e98-106. PubMed ID: 26424550
[TBL] [Abstract][Full Text] [Related]
4. The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression.
Serrano-Villar S; Gutiérrez C; Vallejo A; Hernández-Novoa B; Díaz L; Abad Fernández M; Madrid N; Dronda F; Zamora J; Muñoz-Fernández MÁ; Moreno S
J Infect; 2013 Jan; 66(1):57-66. PubMed ID: 23046968
[TBL] [Abstract][Full Text] [Related]
5. Cross-sectional study of CD4: CD8 ratio recovery in young adults with perinatally acquired HIV-1 infection.
Pollock KM; Pintilie H; Foster C; Fidler S
Medicine (Baltimore); 2018 Feb; 97(8):e9798. PubMed ID: 29465561
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and determinants of T-cell phenotype normalization in HIV-1-infected individuals receiving long-term antiretroviral therapy.
Ndumbi P; Gillis J; Raboud J; Cooper C; Hogg RS; Montaner JS; Burchell AN; Loutfy MR; Machouf N; Klein MB; Tsoukas C;
HIV Med; 2014 Mar; 15(3):153-64. PubMed ID: 24304582
[TBL] [Abstract][Full Text] [Related]
7. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
Kaufmann GR; Furrer H; Ledergerber B; Perrin L; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Rickenbach M; Hirschel B; Battegay M;
Clin Infect Dis; 2005 Aug; 41(3):361-72. PubMed ID: 16007534
[TBL] [Abstract][Full Text] [Related]
8. Immune recovery in HIV-1 infected patients with sustained viral suppression under long-term antiretroviral therapy in Ethiopia.
Wolday D; Legesse D; Kebede Y; Siraj DS; McBride JA; Striker R
PLoS One; 2020; 15(10):e0240880. PubMed ID: 33091053
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation.
Steel A; Cox AE; Shamji MH; John L; Nelson M; Henderson DC; Gotch FM; Gazzard BG; Kelleher P
Antivir Ther; 2007; 12(6):971-5. PubMed ID: 17926652
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy.
Torti C; Prosperi M; Motta D; Digiambenedetto S; Maggiolo F; Paraninfo G; Ripamonti D; Cologni G; Fabbiani M; Caputo SL; Sighinolfi L; Ladisa N; El-Hamad I; Quiros-Roldan E; Frank I
Clin Microbiol Infect; 2012 May; 18(5):449-58. PubMed ID: 21919996
[TBL] [Abstract][Full Text] [Related]
11. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
[TBL] [Abstract][Full Text] [Related]
12. Incomplete Recovery of CD4 Cell Count, CD4 Percentage, and CD4/CD8 Ratio in Patients With Human Immunodeficiency Virus Infection and Suppressed Viremia During Long-term Antiretroviral Therapy.
Mutoh Y; Nishijima T; Inaba Y; Tanaka N; Kikuchi Y; Gatanaga H; Oka S
Clin Infect Dis; 2018 Aug; 67(6):927-933. PubMed ID: 29509894
[TBL] [Abstract][Full Text] [Related]
13. Determinants of suboptimal CD4
Handoko R; Colby DJ; Kroon E; Sacdalan C; de Souza M; Pinyakorn S; Prueksakaew P; Munkong C; Ubolyam S; Akapirat S; Chiarella J; Krebs S; Sereti I; Valcour V; Paul R; Michael NL; Phanuphak N; Ananworanich J; Spudich S;
J Int AIDS Soc; 2020 Sep; 23(9):e25585. PubMed ID: 32949118
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive evaluation of the immune risk phenotype in successfully treated HIV-infected individuals.
Ndumbi P; Gilbert L; Tsoukas CM
PLoS One; 2015; 10(2):e0117039. PubMed ID: 25647167
[TBL] [Abstract][Full Text] [Related]
15. Evolution of CD4+ T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppression.
Byakwaga H; Murray JM; Petoumenos K; Kelleher AD; Law MG; Boyd MA; Emery S; Mallon PW; Cooper DA
AIDS Res Hum Retroviruses; 2009 Jun; 25(6):756-76. PubMed ID: 19500017
[TBL] [Abstract][Full Text] [Related]
16. HIV Reservoir Decay and CD4 Recovery Associated With High CD8 Counts in Immune Restored Patients on Long-Term ART.
Zhang LX; Jiao YM; Zhang C; Song JW; Fan X; Xu RN; Huang HH; Zhang JY; Wang LF; Zhou CB; Jin L; Shi M; Wang FS
Front Immunol; 2020; 11():1541. PubMed ID: 32793212
[No Abstract] [Full Text] [Related]
17. Interferon lambda rs368234815 ΔG/ΔG is associated with higher CD4
Freitas IT; Tinago W; Sawa H; McAndrews J; Doak B; Prior-Fuller C; Sheehan G; Lambert JS; Muldoon E; Cotter AG; Hall WW; Mallon PWG; Carr MJ
AIDS Res Ther; 2020 Apr; 17(1):13. PubMed ID: 32295609
[TBL] [Abstract][Full Text] [Related]
18. Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell Counts.
Cao W; Mehraj V; Trottier B; Baril JG; Leblanc R; Lebouche B; Cox J; Tremblay C; Lu W; Singer J; Li T; Routy JP; ; Vézina S; Charest L; Milne M; Huchet E; Lavoie S; Friedman J; Duchastel M; Villielm F; Côté P; Potter M; Lessard B; Charron MA; Dufresne S; Turgeon ME; Rouleau D; Labrecque L; Fortin C; de Pokomandy A; Hal-Gagné V; Munoz M; Deligne B; Martel-Laferrière V; Gilmore N; Fletcher M; Szabo J
Clin Infect Dis; 2016 Jan; 62(2):250-257. PubMed ID: 26349551
[TBL] [Abstract][Full Text] [Related]
19. CD4/CD8 ratio, comorbidities, and aging in treated HIV infected individuals on viral suppression.
Passos DF; Bremm JM; da Silveira LL; Jantsch MH; da Silva JLG; Disconzi E; Rezer JFP; Schwarzbold AV; Marques ACF; Schetinger MRC; Leal DBR
J Med Virol; 2020 Dec; 92(12):3254-3264. PubMed ID: 32314818
[TBL] [Abstract][Full Text] [Related]
20. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.
Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
Antivir Ther; 2013; 18(1):125-30. PubMed ID: 22805174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
